390 related articles for article (PubMed ID: 9510258)
1. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
[TBL] [Abstract][Full Text] [Related]
2. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
[TBL] [Abstract][Full Text] [Related]
3. Optimized sentinel node scintigraphy in breast cancer.
Paganelli G; De Cicco C; Cremonesi M; Prisco G; Calza P; Luini A; Zucali P; Veronesi U
Q J Nucl Med; 1998 Mar; 42(1):49-53. PubMed ID: 9646645
[TBL] [Abstract][Full Text] [Related]
4. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.
Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M;
Eur J Cancer; 2005 Jan; 41(2):238-43. PubMed ID: 15661548
[TBL] [Abstract][Full Text] [Related]
5. Lymphoscintigraphy and gamma probe tracing in detecting breast cancer lymph node involvement: can they replace axillary lymph node dissection?
Vaggelli L; Castagnoli A; Distante V; Orzalesi L; Cataliotti L; Cesco P
Tumori; 2000; 86(4):322-4. PubMed ID: 11016716
[TBL] [Abstract][Full Text] [Related]
6. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
[TBL] [Abstract][Full Text] [Related]
7. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
10. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
[TBL] [Abstract][Full Text] [Related]
11. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
12. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
[TBL] [Abstract][Full Text] [Related]
13. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
[TBL] [Abstract][Full Text] [Related]
14. Localization of the sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intraoperative gamma probe.
Villa G; Gipponi M; Buffoni F; Vecchio C; Bianchi P; Agnese G; Di Somma C; Catturich A; Rosato F; Tomei D; Nicolò G; Badellino F; Mariani G; Canavese G
Tumori; 2000; 86(4):297-9. PubMed ID: 11016707
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
Nwariaku FE; Euhus DM; Beitsch PD; Clifford E; Erdman W; Mathews D; Albores-Saavedra J; Leitch MA; Peters GN
Am J Surg; 1998 Dec; 176(6):529-31. PubMed ID: 9926784
[TBL] [Abstract][Full Text] [Related]
16. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node identification in breast cancer patients.
Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative localization of the sentinel node in breast cancer: technical aspects of lymphoscintigraphic methods.
De Cicco C; Chinol M; Paganelli G
Semin Surg Oncol; 1998 Dec; 15(4):268-71. PubMed ID: 9829385
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.
Schrenk P; Hochreiner G; Fridrik M; Wayand W
Breast J; 2003; 9(4):282-7. PubMed ID: 12846861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
